Page last updated: 2024-08-22

misonidazole and Leukemia L 1210

misonidazole has been researched along with Leukemia L 1210 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mulcahy, RT; Siemann, DW1
Erickson, LC; McManus, ME; Ramonas, LM1
Scavone, SV; Sebolt-Leopold, JS1
Adomat, H; Chaplin, DJ; Farrell, NP; Skov, KA1

Other Studies

4 other study(ies) available for misonidazole and Leukemia L 1210

ArticleYear
In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Cancer research, 1983, Volume: 43, Issue:10

    Topics: Animals; Carmustine; Cell Line; Drug Resistance; Drug Synergism; Humans; Leukemia L1210; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Sarcoma, Experimental

1983
The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
    Molecular pharmacology, 1982, Volume: 22, Issue:1

    Topics: Anaerobiosis; Animals; Antineoplastic Agents; Cells, Cultured; Cross-Linking Reagents; Cyclophosphamide; DNA, Neoplasm; Drug Interactions; Leukemia L1210; Mice; Misonidazole; Nitroimidazoles; Oxygen

1982
Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: Alkylating Agents; Animals; Carmustine; Drug Synergism; In Vitro Techniques; Isoquinolines; Leukemia L1210; Misonidazole; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin; Tumor Cells, Cultured

1992
Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Anti-cancer drug design, 1990, Volume: 5, Issue:1

    Topics: Aerobiosis; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cisplatin; DNA; DNA Restriction Enzymes; Drug Design; Drug Resistance; Leukemia L1210; Metronidazole; Misonidazole; Oxidation-Reduction; Tumor Cells, Cultured

1990